The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
COVID-19 Vaccine Development & Implementation Workshop 2021 - June Edition
Related Enduring Materials
Enduring Materials
Enduring Materials
Day 1 - Tuesday, 29 June
Session 1: Current Situation -
The WHO Global Study of the Origins of SARS-CoV-2
COVID-19 Vaccine Implementation in the United States
Updates on COVID-19 Epidemiology and Vaccination
COVID-19 Vaccine in Special Groups
COVID-19 Vaccine Safety and Toxicity
Session 2: Vaccine Development -
Kathryn Stephenson, MD, MPH
Penny Moore, PhD
Phylogenetic Analysis and Genomic Epidemiology of SARS-CoV-2
Toward a Universal Coronavirus Vaccine
Current Vaccine Platforms - The More the Merrier?
Harvard Medical School / Ragon Institute / Beth Israel Deaconess Medical Center, United States
SARS-CoV-2 Variants and Vaccines
Vaccine Boosting, When, with What, and Does Previous Infection Matter?
University of the Witwatersrand / National Institute for Communicable Diseases, South Africa
Day 2 - Wednesday, 30 June
Session 3: Vaccines and Diagnostics -
Update on SARS-CoV-2 Virological Diagnostics
How to Assess Protection Against Infection and Transmission After Vaccination?
Adapting Diagnostics to SARS-CoV-2 Viral Variants
COVID NAb testTM. A Quantitative Neutralising Antibody Lateral Flow point of care assay
Session 4: Vaccines Here to Stay? What Else is Needed -
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Eyal Leshem, MD
Challenges to Global Access Equity
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
COVID-19 Vaccines: Impact and Effectiveness in Preventing Infection and Transmission
Director of the Center for Travel Medicine and Tropical Diseases, Sheba Medical Center
Clinical Trial Designs for Evaluating COVID-19 Vaccine Effects on Transmission
SARS-CoV-2 mAbs for Prevention of COVID-19
Overview
Image
In Memoriam: Dr. Charles Boucher
We are deeply saddened to share that Dr. Charles Boucher, a Program Director of the COVID-19 Vaccine Development & Implementation Workshop 2021, has passed away after a courageous battle with cancer. Read our full memorial >
What's New
-
Enduring materials are now available on this website.
Thank You Message
The workshop on COVID-19 Vaccine Development & Implementation Workshop 2021 - June Edition was held virtually on 29 - 30 June 2021. Please visit the Enduring Materials tab for related slidesets and videos of our faculty to this workshop.
The COVID-19 Vaccine Development & Implementation Workshop aimed to increase knowledge and facilitate discussion on the many aspects of vaccine development and rollout on a background of a firm understanding of pathogenesis and natural infection. Our goal was to address the many scientific, social, and policy challenges in the totality of delivering an effective COVID-19 vaccine.
This global program hoped to promote understanding and stimulate further discussion and research among virologists, infectious diseases specialists, community, and policymakers. This was done in the truly global context of the COVID-19 pandemic, considering regional differences in access to medications, health system capacity, and public measures.
Topics of Interest
- Emerging clinical data for several more vaccines being approved in
the meantime; - Impact of vaccination on country rates of COVID-19;
- Durability of immunity;
- Vaccines in children; and
- Impact of new virus variants on protection.
Who Should Attend
- Virologists, immunologists, and scientists involved or interested in vaccine research and physicians caring for COVID-19 patients;
- Nurses, and other healthcare professionals involved in the care of COVID-19; patients, policymakers, and (non)government representatives; and
- Healthcare administrators.
Learning Objectives
At the completion of the program participants will:
- Acquire up-to-date knowledge on COVID-19 epidemiology, vaccination rates, and safety and toxicity data
- Comprehend the impact of new SARS-CoV-2 variants on vaccine efficacy and effectiveness
- Increase understanding of SARS-CoV-2 diagnostics, including emerging variants
- Increase knowledge on the COVID-19 vaccine development
- Understand vaccine-induced protection against infection and transmission, both in real-world settings and modeling studies
Disclaimer
This program is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this program, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this program. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the program.
Committees
Support
This workshop is supported by:
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in COVID-19.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Mr. Kun-Chieh Wu at kun-chieh.wu@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company. *Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Digital and printed advertising opportunities
- Social media shout-outs
*Subject to the support level.
Endorsers
The workshop is endorsed by the following organizations:
Media Partner:
Previous Edition
Video selections from the previous edition
Will SARS Cov-2 Become Resistant to Current Vaccines
Penny Moore, PhD from National Health Laboratory Service, South Africa
Reinfection and Protective Immunity After COVID Infection
David W. Eyre, BM, BCh, DPhil from University of Oxford, United Kingdom
Post Vaccination Antibody Testing: Its Role for Determining Level
Benjamin Larimer, PhD from University of Alabama at Birmingham, United States of America
